Product News

Masimo Technology to Select Philips Monitors
Product News

New Deal Brings Masimo Technology to Select Philips Monitors

Masimo and Royal Philips both global leaders in patient monitoring, announced that they have reinforced their partnership, whereby Philips will integrate additional Masimo measurement technologies into select IntelliVue® MX-series multi-parameter monitors, to help clinicians assess cerebral oximetry and ventilation status. Core Masimo noninvasive measurements, such as SET® Measure-through Motion and […]

respiraWorks logo open-source ventilator
Product News

Shortage Sparks Partnership For Open-Source Ventilators 🎧

[playht_player width=”100%” height=”175″ voice=”Noah”]RespiraWorks, a nonprofit innovator of ventilators for developing countries, and Integrated Computer Solutions (ICS), creators of sophisticated embedded and touchscreen-enabled devices, announced a partnership to collaborate on RespiraWorks’ open-source ventilator. The medical-grade device, which can be assembled for under $500, is being designed for long-term vs. crisis use and for […]

artificial lung extracorporeal carbon dioxide removal a lung
Product News

ALung Announces Commercial Development of Next Generation Artificial Lung

ALung Technologies, Inc. announced the recent initiation of commercial development of its next-generation artificial lung, which expands the Company’s focus on highly efficient gas exchange devices and also broadens its applicable market. The Company’s current product, the Hemolung® Respiratory Assist System (RAS), is the only fully comprehensive extracorporeal carbon dioxide removal […]

abiomed_Breethe_Full_Machine_white_bg
Product News

Abiomed Acquires Breethe ECMO System

Abiomed, maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system that will complement and expand Abiomed’s product portfolio to more comprehensively serve the needs of patients whose lungs can no longer provide sufficient oxygenation, including patients suffering from cardiogenic shock or respiratory […]

inspire hypoglossal nreve stimulation
Product News

FDA Approves Expanded Age Range for Inspire Therapy

Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (“FDA”) has approved an expanded age range for Inspire therapy to include 18-21-year-old patients, as compared to the previous minimum age requirement for patients to be 22 years old. Following a detailed review of the clinical evidence […]